CareDx Q2 Revenues Rise 4 Percent; Miss Analyst Estimates | GenomeWeb

NEW YORK (GenomeWeb) – CareDx said after the close of the market on Monday that its revenues for the second quarter increased 4 percent year over year. 

For the three months ended June 30, the Brisbane, California-based firm recorded $7.1 million in total revenues, up from $6.8 million in Q2 2014. It missed the consensus Wall Street estimate of $7.3 million. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.